Editor, Pharmaceutical and Health, CNBC TV18. Reporting, Analysing Pharma & Health since 2008. Tweets personal. Coffee & puppy addict. Myopic bt not in my views
What a week. 2nd award in a week! Been awarded the Best continuing coverage by a reporter at the ENBA Broadcast awards. Bronze. Couldn't have done it without the fabulous team @cnbctv18india ❤️
CIPLA SIGNS ONCOLOGY DEAL W/ CHINA’S SINO BIOPHARM 🇨🇳💊
• Gets exclusive rights to Cancer drug TQB2102
• Rights cover India South Africa + 5 EMs
• Drug shows potential in HER2-low breast cancer
• Cipla to handle lcommercialisation
• Sino's arm CTTQ to manf drug
@CNBCTV18Live
SUN PHARMA SIGNS US DEAL 🇺🇸💊
• Agrees to extend MFN pricing to US Medicaid
• Commits to MFN pricing for future innovative meds
• Section 232 tariffs on innovative drugs delayed for 2+ years
• US accounts for ~27% ofglobal revenue
*MFN: Most Favored Nation @CNBCTV18Live
MOLBIO DIAGNOSTICS Sees a strong listing
Innovation driven co, large dependence on TB
Truenat breast & cervical cancer could be a large mrkt
60% of pathology market is US
Got USFDA approval 6 weeks ago for a product
No M&A plans as of nw @CNBCTV18Live